Lung Cancer Clinical Trial

Biofeedback Training in Patients With Advanced Lung Cancer – A Pilot Study

Summary

This is a pilot study to test the hypothesis that biofeedback-mediated stress management (BFSM) training can be used to reduce distress and enhance quality of life in patients with non-small cell lung cancer (NSCLC). Most patients with advanced NSCLC have significant physical symptoms, but even those who do not have physical symptoms have high levels of anxiety and depression.

View Full Description

Full Description

Biofeedback-mediated stress management (BFSM) involves helping patients to visualize the reactions which their own bodies have to stressful situations (increased heart rate, increased skin conductance, increased muscle tension, decreased digital peripheral temperature, decreased heart rate variability) and then teaching them to control these reactions, using standard stress management and relaxation techniques, coupled with computerized physiological feedback. The feedback helps patients to understand that deep relaxation is helping their bodies as well as their minds. Several small studies of BFSM training in cancer populations have been successful at helping with side effects of chemotherapy and radiation, but the effects of BFSM on distress and quality of life (QOL), particularly in NSCLC patients, have not been studied.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with a new diagnosis of advanced (stage IV) non-small cell lung cancer (NSCLC)
ECOG performance status 0-1.
Plan to receive care at the Taussig Cancer Center.

Exclusion Criteria:

Non-local patients, who will not have the ability to return for 8 study visits.
Patients who are unable to speak and understand English readily,
Patients with significant cognitive impairment.

Study is for people with:

Lung Cancer

Estimated Enrollment:

8

Study ID:

NCT01685346

Recruitment Status:

Terminated

Sponsor:

Case Comprehensive Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center
Cleveland Ohio, 44195, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

8

Study ID:

NCT01685346

Recruitment Status:

Terminated

Sponsor:


Case Comprehensive Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider